CME; TAR-200; TAR-210; SunRISe trials; MoonRISe trials

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Trial in Progress: Phase 3 MoonRISe-3 Study
Trial in Progress: Phase 3 MoonRISe-3 Study
Oncology and Hematology
Trial in Progress: Phase 3 MoonRISe-3 Study
Personalizing Care Within the RCC Treatment Paradigm
Personalizing Care Within the RCC Treatment Paradigm
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credit
- Eric Jonasch, MD
- Brad McGregor, MD
- Ulka Vaishampayan, MBBS
1.00 credit
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
0.50 program credits
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 program credits
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
0.50 program credits
- Sandra Swain, MD
- Virginia Kaklamani, MD
0.50 program credits

First Results From Cohort 4 of the SunRISe-1 Trial